Sunil V. Rao · Oct 18, 2020 · 3:01 PM UTC

Sunil V. Rao

16Media

Amit N. Vora, MD MPH retweeted

Sunil V. Rao@SVRaoMD18 Oct 2020

Congratulations to @JAGutierrezMD for his @vahsrd Career Development Award!! This provides 5 years of full salary & study support for his important project examining the role of telehealth on functional status & outcomes in pts w/PAD. @vadurham @HastingsNicki @DukeCardiology

Associate Deans · Mar 11, 2020 · 1:57 AM UTC

Amit N. Vora, MD MPH retweeted

Associate Deans@ass_deans11 Mar 2020

We have cancelled all nonessential travel. Whether athletics is covered by the ban depends on whether the basketball team gets off the bubble and into the NCAA tournament.

139

992

Dr. Gilbert Tang · Feb 25, 2020 · 10:46 PM UTC

Amit N. Vora, MD MPH retweeted

Dr. Gilbert Tang

@GilbertTangMD25 Feb 2020

Replying to @GilbertTangMD @ajc

Here's the central Figure. @tnazifMD @PradeepYadavMD @PaulMahoneyMD @mirvatalasnag @ZeroTLR @jtsaxon @lamelaspablo @colum_owens @MDT_StructHeart @anvoramd @AnkurKalraMD @HarryDauerman @TheNarulaSeries @Almanfi_Cardio @bkolskk @BGalperMD @JoaoLCavalcante @DrMoritzWvB @ekgpdx

Image from Dr. Gilbert Tang (@GilbertTangMD)

Circulation · Sep 28, 2019 · 3:15 PM UTC

Amit N. Vora, MD MPH retweeted

Circulation@CircAHA28 Sep 2019

AUGUSTUS: high risk of rehospitalization in patients w/AF and ACS or PCI, but is lower among patients treated with apixaban than VKA. @anvoramd @RenatoDLopes1 @DCRINews @AHAScience #CIRCTCT19 #AHAJournals #TCT2019 ow.ly/tGs350wqyKA

Marat Fudim, MD MHS · Sep 29, 2019 · 3:27 PM UTC

Amit N. Vora, MD MPH retweeted

Marat Fudim, MD MHS@FudimMarat29 Sep 2019

Winners of 2019 @ACCinTouch NC/SC FIT Jeopardy 👉 @dukeheartfellow @ZakLoringMD @dmanly23 Look forward to represent NC at #ACC2020. @rsloungani @NavidNafissi @manesh_patelMD @DukeHFDoc @robmentz

Image from Marat Fudim, MD MHS (@FudimMarat)

Duke Clinical Research Institute · Sep 12, 2019 · 3:07 PM UTC

Amit N. Vora, MD MPH retweeted

Duke Clinical Research Institute@DCRINews12 Sep 2019

AUGUSTUS -- Antithrombotic Therapy after Acute Coronary Syndrome or #PCI in #AFib -- among Top 10 most viewed articles on New England Journal of Medicine website -- learn more about AUGUSTUS dcri.org/acc-2019-augustus/ @NEJM @RenatoDLopes1

Image from Duke Clinical Research Institute (@DCRINews)

Circulation · Sep 26, 2019 · 7:45 PM UTC

Amit N. Vora, MD MPH retweeted

Circulation@CircAHA26 Sep 2019

AUGUSTUS: Apixaban and P2Y12 inhibitor consistently better safety and similar efficacy as ASA or VKA groups in AF with ACS whether managed medically or w/PCI, or elective PCI. @RenatoDLopes1 @DCRINews @AHAScience#CIRCTCT19 #AHAJournals #TCT2019 ow.ly/po8J50wqxdR

C. Michael Gibson MD · Sep 26, 2019 · 8:21 PM UTC

Amit N. Vora, MD MPH retweeted

C. Michael Gibson MD

@CMichaelGibson26 Sep 2019

Watch the discussion between @RenatoDLopes1 and I about the medically ill patients in AUGUSTUS. tv.clinicaltrialresults.org/… #TCT2019

Image from C. Michael Gibson MD (@CMichaelGibson)

Duke Clinical Research Institute · Sep 27, 2019 · 5:05 PM UTC

Amit N. Vora, MD MPH retweeted

Duke Clinical Research Institute@DCRINews27 Sep 2019

“…Our results are reassuring about the safety and efficacy of using apixaban plus a P2Y12 inhibitor without aspirin as the preferred antithrombotic regimen in patients with AF and ACS…” ~ @RenatoDLopes1 discussing AUGUSTUS | Learn more in @CircAHA bit.ly/2m4oWeR

Srihari S. Naidu, MD · Sep 28, 2019 · 5:33 PM UTC

Amit N. Vora, MD MPH retweeted

Srihari S. Naidu, MD

@SrihariNaiduMD28 Sep 2019

Congrats #scaielm @SCAI @jaygirimd for winning the Linnemeier Young Investigator Award! @cardiacpolymath @chadialraies @SVRaoMD @DrSheilaSahni @GreggWStone @TCTConference

Image from Srihari S. Naidu, MD (@SrihariNaiduMD)